Please use this identifier to cite or link to this item:
|Title:||Investigation of the role of the thiazolidinedione ring of troglitazone in inducing hepatotoxicity||Authors:||Saha, S.
|Issue Date:||1-Feb-2010||Citation:||Saha, S., New, L.S., Ho, H.K., Chui, W.K., Chan, E.C.Y. (2010-02-01). Investigation of the role of the thiazolidinedione ring of troglitazone in inducing hepatotoxicity. Toxicology Letters 192 (2) : 141-149. ScholarBank@NUS Repository. https://doi.org/10.1016/j.toxlet.2009.10.014||Abstract:||Troglitazone (TGZ) is an orally active hypoglycemic agent which is used for the treatment of non-insulin-dependent diabetes mellitus. It had been associated with severe drug-induced liver failure which resulted in its withdrawal from the market in 2000. While the exact mechanism of its toxicity remains unknown, it has been postulated that the formation of toxic reactive metabolites (RMs) may play an important role in the hepatotoxicity of TGZ. The purpose of this study is to investigate the role of sulfur moiety of thiazolidinedione (TZD) nucleus in inducing liver toxicity via the formation of RMs. An analogue of TGZ, trosuccinimide (TSN), was synthesized chemically where the sulfur moiety of thiazolidinedione ring was replaced by a methylene group. Both compounds were incubated independently with human liver microsomes enriched with glutathione (GSH) and normal human hepatocytes (THLE-2 cell lines) to profile GSH-adducts using ultra performance liquid chromatography tandem mass spectrometry (UPLC/MS/MS). Four RM-GSH conjugates of TGZ were identified during the profiling experiments of which three were related to the sulfur moiety of the TZD ring, whereas no RM of TSN was detected in both microsomes and hepatocytes. MTT, GSH and protein carbonyl (PC) assays were performed using THLE-2 hepatocytes to measure the levels of toxicity of TGZ and TSN in vitro. Finally, peroxisome proliferator activated receptor gamma (PPARγ) binding activity was measured to check the binding affinities of both TGZ and TSN. The calculated binding affinities of TGZ and TSN were 332.2 and 1106.0 μM, respectively. Our results indicated collectively that TSN (EC50 = 138.5 ± 7.32 μM) was less toxic than TGZ (EC50 = 27.2 ± 4.8 μM) in THLE-2 hepatocytes. As both compounds were shown to bind to PPARγ, the substitution of the TZD moiety may be beneficial from a drug design perspective. In conclusion, our study confirmed that the TZD ring of TGZ may be partially responsible for its liver toxicity in humans via the formation of RMs. © 2009 Elsevier Ireland Ltd. All rights reserved.||Source Title:||Toxicology Letters||URI:||http://scholarbank.nus.edu.sg/handle/10635/106087||ISSN:||03784274||DOI:||10.1016/j.toxlet.2009.10.014|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Dec 12, 2019
WEB OF SCIENCETM
checked on Dec 12, 2019
checked on Nov 30, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.